Innovation in active and passive immunisation of people who are immunocompromised: a call to action
Joshua A. Hill, Jim Boonyaratanakornkit, Malgorzata Mikulska, Benjamin W. Teh et autres
10 citationsThe Lancet Infectious Diseases
William O. Hahn
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
28Publications signalées
1028Citations signalées
4Affiliations récentes
Institutions déclarées
Domaines associés
HIV Research and TreatmentMalaria Research and ControlSARS-CoV-2 and COVID-19 ResearchImmunotherapy and Immune ResponsesSepsis Diagnosis and Treatment
Publications récentes
Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial
K. Rachael Parks, Zoe Moodie, Mary Allen, Catherine Yen et autres
44 citationsScience Translational Medicine
Dose finding in early-phase human immunodeficiency virus type 1 prevention monoclonal antibody clinical trials
Yunda Huang, Bo Zhang, Lily Zhang, Bryan T. Mayer et autres
1 citationClinical Trials
Japanese encephalitis presenting as transverse myelitis in a traveller to Indonesia: a cautionary note for surfers
William O. Hahn, Carol Glaser, Susan L. Hills, Lynn Fitzgibbons
2 citationsJournal of Travel Medicine
Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data
Leah Andrews, M. Elizabeth Halloran, Lars van der Laan, Yunda Huang et autres
6 citationsJAMA Network Open
Safety and implementation of phase I randomized GLA-SE–adjuvanted CH505TF gp120 HIV vaccine trial in newborns
Avy Violari, Kennedy Otwombe, William O. Hahn, Shi‐Yu Chen et autres
5 citationsJournal of Clinical Investigation
Safety and implementation of a phase 1 randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns
Avy Violari, Kennedy Otwombe, William O. Hahn, Shi‐Yu Chen et autres
2 citationsmedRxiv
HIV BG505 SOSIP.664 trimer with 3M-052-AF/alum induces human autologous tier-2 neutralizing antibodies
William O. Hahn, K. Rachael Parks, Mingchao Shen, Gabriel Ozorowski et autres
6 citationsmedRxiv
SARS-CoV-2 Variant is Strongly Associated with Peak Viral Load and Shedding Duration with Minimal Impact from Host Factors: Results from the CoVPN 5001 Study
William O. Hahn, Leigh H. Fisher, Amy Ward, Shannon Grant et autres
0 citationsSSRN Electronic Journal
Targeting enhanced neutralizing antibody responses via increased germinal center activity: early-phase vaccine trials with novel clinical designs
William O. Hahn, Joshua A. Hill, James G. Kublin
2 citationsCurrent Opinion in HIV and AIDS
Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials
Alfredo J Mena Lora, Jessica E. Long, Yunda Huang, Lindsey R. Baden et autres
38 citationsJAMA Network Open
COVID-19 Vaccines
William O. Hahn, Zanthia Wiley
25 citationsInfectious Disease Clinics of North America
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.